JP2016528165A5 - - Google Patents

Download PDF

Info

Publication number
JP2016528165A5
JP2016528165A5 JP2016509176A JP2016509176A JP2016528165A5 JP 2016528165 A5 JP2016528165 A5 JP 2016528165A5 JP 2016509176 A JP2016509176 A JP 2016509176A JP 2016509176 A JP2016509176 A JP 2016509176A JP 2016528165 A5 JP2016528165 A5 JP 2016528165A5
Authority
JP
Japan
Prior art keywords
hydroxy
alkyl
aliphatic hydrocarbon
composition according
cyclo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016509176A
Other languages
English (en)
Japanese (ja)
Other versions
JP6641263B2 (ja
JP2016528165A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2014/072508 external-priority patent/WO2015025980A1/en
Publication of JP2016528165A publication Critical patent/JP2016528165A/ja
Publication of JP2016528165A5 publication Critical patent/JP2016528165A5/ja
Application granted granted Critical
Publication of JP6641263B2 publication Critical patent/JP6641263B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016509176A 2013-08-22 2014-08-21 神経障害性疼痛の処置方法 Expired - Fee Related JP6641263B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361868750P 2013-08-22 2013-08-22
US61/868,750 2013-08-22
US201361918124P 2013-12-19 2013-12-19
US61/918,124 2013-12-19
PCT/JP2014/072508 WO2015025980A1 (en) 2013-08-22 2014-08-21 Method for treating neuropathic pain

Publications (3)

Publication Number Publication Date
JP2016528165A JP2016528165A (ja) 2016-09-15
JP2016528165A5 true JP2016528165A5 (enExample) 2017-09-28
JP6641263B2 JP6641263B2 (ja) 2020-02-05

Family

ID=52480928

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016509176A Expired - Fee Related JP6641263B2 (ja) 2013-08-22 2014-08-21 神経障害性疼痛の処置方法

Country Status (4)

Country Link
US (1) US20150057351A1 (enExample)
EP (1) EP3035925A4 (enExample)
JP (1) JP6641263B2 (enExample)
WO (1) WO2015025980A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA037327B1 (ru) 2015-09-22 2021-03-12 Грейбуг Вижн, Инк. Соединения и композиции для лечения глазных расстройств
CA3049389A1 (en) * 2017-01-06 2018-07-12 Clexio Biosciences Ltd. Topical detomidine formulations

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1322749C (en) 1987-01-28 1993-10-05 Ryuzo Ueno Prostaglandins of the d series, and tranquilizers and soporifics containing the same
US5166174A (en) 1987-01-28 1992-11-24 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti-ulcers containing same
US5221763A (en) 1987-04-30 1993-06-22 R-Tech Ueno, Ltd. Prostaglandins of the F series
CA2039420C (en) 1990-04-04 1996-12-10 Ryuji Ueno Treatment of cataract with 15-keto-prostaglandin compounds
CA2150287C (en) 1994-06-03 2004-08-10 Ryuji Ueno Agent for treating hepato-biliary diseases
DK0857718T3 (da) 1996-06-10 2002-12-16 Sucampo Ag Endothelinantagonist
PT1305082E (pt) * 2000-07-21 2004-09-30 Ortho Mcneil Pharm Inc Compostos de carbamato para utilizacao na prevencao ou tratamento da dor neuropatica e dor associada a cefaleia de salvas e enxaqueca
HUP0304063A3 (en) * 2001-02-22 2005-05-30 Ono Pharmaceutical Co Medicinal compositions comprising diclofenac and ornoprostil
MXPA04002006A (es) * 2001-08-31 2004-06-07 Sucampo Ag Analogos de prostagladina como abridor del canal de cloruro.
CN1950085A (zh) * 2004-05-11 2007-04-18 因赛特公司 作为趋化因子受体调节剂的3-(4-杂芳基环己基氨基)环戊烷羧酰胺
CN103919783A (zh) * 2005-03-04 2014-07-16 苏坎波公司 治疗外周血管病的方法和组合物
US20090030072A1 (en) * 2007-07-03 2009-01-29 Sucampo Ag Pharmaceutical combination of opioid and prostaglandin compound
JP2010106019A (ja) * 2008-10-02 2010-05-13 Kanazawa Univ リマプロストを含有してなる癌化学療法に起因する末梢神経障害予防、治療および/または症状軽減剤
US20110034424A1 (en) * 2009-06-30 2011-02-10 Sucampo Ag Method for the long term nsaid use
SG10201606442QA (en) * 2011-08-05 2016-09-29 Sucampo Ag Method for treating schizophrenia

Similar Documents

Publication Publication Date Title
JP2014505660A5 (enExample)
WO2016012965A3 (en) Substituted phenyl alkanoic acid compounds as gpr120 agonists and uses thereof
JP2015518491A5 (enExample)
WO2013121449A8 (en) Compositions and methods for the modulation of specific amidases for n-acylethanolamines for use in the therapy of inflammatory diseases
EA201590624A1 (ru) Циклические эфиры пиразол-4-ил-гетероциклил-карбоксамидных соединений и способы их применения
WO2012122340A8 (en) Soluble guanylate cyclase activators
AR072990A1 (es) Compuestos de tetraciclina sustituidos con fluor en c7
JP2016511753A5 (enExample)
JP2011527345A5 (enExample)
RU2014135436A (ru) Комбинация ингибитора rtk с антиэстрогеном и ее применение для лечения рака
JP2015508092A5 (enExample)
JP2013518036A5 (enExample)
RU2014118123A (ru) Энантиомеры-2-гидроксипроизводных жирных кислот
WO2011100502A8 (en) 7-aminofuropyridine derivatives
JP2004527567A5 (enExample)
RU2012144438A (ru) Производные 1-(2-фторбифенил-4-ил)-алкилкарбоновой кислоты для лечения транстиретинового амилоидоза
RU2012146325A (ru) Терапевтическое средство или профилактическое средство для лечения фибромиалгии
RU2013136895A (ru) Новое бициклическое соединение или его соль
RU2018113296A (ru) Фармацевтическая композиция, содержащая 11-дезокси-простагландиновое соединение и способ стабилизации этого соединения
JP2014511825A5 (enExample)
PH12019500618A1 (en) Pharmaceutical composition and method for treatment of non-alcoholic fatty liver disease
JP2016528165A5 (enExample)
JP2010533707A5 (enExample)
RU2013151166A (ru) Способ модуляции активности цитокинов
JP2008528440A5 (enExample)